Protein Expression Market Share, Development and Demand Forecast to 2030

The protein expression market is expected to expand from USD 3,184.8 million in 2023 to USD 7,774.8 million by 2030, with a compound annual growth rate (CAGR) of 13.7% from 2024 to 2030. Protein expression refers to the alteration, synthesis, and regulation of proteins in living organisms. In protein research, this term can denote either the subject under study or the laboratory techniques used for protein production.

Proteomics supports the study of recombinant protein expression across various host systems, where protein expression is essential.

Proteins are synthesized and regulated according to their functional needs within the cell. DNA contains the blueprints for proteins, which are decoded by tightly controlled transcription processes to produce messenger mRNA. This mRNA is then translated into protein.

In the system segment, protein expression is categorized into six types: prokaryotic expression systems, mammalian cell expression systems, cell-free expression systems, yeast expression systems, and insect cell expression systems. Prokaryotic expression systems hold the largest market share due to their lower cost compared to mammalian and insect cell systems. In prokaryotes, transcription and translation occur simultaneously, with translation beginning before the mRNA is fully synthesized. In contrast, these processes are spatially and temporally separated in eukaryotes, with transcription occurring in the nucleus and translation in the cytoplasm.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=protein-expression-market

In the offering segment, the protein expression industry is divided into instruments, expression vectors, competent cells, reagents, and services. Reagents are expected to capture the largest market share due to the large-scale production of vaccines and antibodies and the increasing research activities in protein expression.

Protein expression has applications in research, industrial, and therapeutic fields. The therapeutic sector is projected to capture the largest market share, driven by the growing prevalence of chronic diseases such as diabetes and cancer, and the expanding protein therapeutics industry.

The major end-users in this industry are biotechnology and pharmaceutical companies, academic research institutes, and contract research organizations, with pharmaceutical and biotechnology companies expected to hold the largest market share in the coming years.

Transcription and Translation

Transcription is the process of transferring information from DNA to mRNA, while translation is the synthesis of proteins based on the mRNA sequence. Transcription occurs in three steps—initiation, elongation, and termination—in both prokaryotes and eukaryotes. It begins with the unwinding of double-stranded DNA to allow RNA polymerase binding, followed by the release of RNA polymerase once transcription starts. In eukaryotes, activators, repressors, and chromatin regulate transcription at multiple levels. In prokaryotes, mRNA does not require special modifications, and translation begins before transcription is complete.

In eukaryotes, mRNA undergoes processing to remove introns (splicing), add multiple adenines at the 3´ end, and cap the 5´ end to generate a polyA tail. The modified mRNA is then exported to the cytoplasm for translation.

Translation involves several steps and includes macromolecules such as ribosomes, tRNA, mRNA, and protein factors, as well as small molecules like ATP, GTP, and amino acids. Each translation step requires specific protein factors, and the process is similar in both eukaryotes and prokaryotes.

The increasing incidence of chronic diseases requiring therapeutic interventions is driving the growth of the protein expression industry.

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.